In spite of these reprogrammed, compensatory metabolic pathways, the dependence of the Fer-deficient cancer cells on glucose, and their jeopardized metabolic plasticity, impacted their proliferation and growth, not only in-vitro, but in-vivo as well. Here, FER is linked to cancer.